Introduction
Jelmyto (mitomycin gel) instillation is an innovative, non-surgical treatment for low-grade upper tract urothelial carcinoma (UTUC). Delivered through a pre-placed nephrostomy tube, this therapy allows for targeted drug delivery directly to the affected area of the urinary tract. At Crossroads Urology, we are proud to offer Jelmyto instillation in our office, providing a convenient and effective option for patients with UTUC.
Indications
Jelmyto instillation is recommended for patients with:
- Low-grade, localized UTUC confirmed through imaging and biopsy.
- A desire to avoid surgical intervention such as nephroureterectomy.
- Suitability for nephrostomy tube placement for direct drug administration.
Procedure
The Jelmyto instillation process involves:
- A nephrostomy tube is pre-placed to provide direct access to the renal pelvis and affected areas.
- Jelmyto, a mitomycin-based gel, is prepared and warmed to ensure proper consistency for instillation.
- The gel is carefully instilled into the nephrostomy tube, allowing it to fill the urinary tract and coat the cancerous tissue.
- The gel solidifies at body temperature, ensuring prolonged contact with the tumor for effective treatment.
- The procedure is typically performed once weekly for six weeks, depending on the treatment plan.
Advantages of In-Office Jelmyto Instillation
- Convenient and comfortable outpatient treatment setting.
- Targeted delivery minimizes systemic exposure and associated side effects.
- High patient compliance with reduced need for hospital-based therapies.
Risks and Complications
While Jelmyto instillation is generally well-tolerated, potential risks include:
- Local irritation or discomfort at the nephrostomy tube site.
- Temporary urinary side effects such as hematuria or dysuria.
- Rare systemic side effects of mitomycin, including fatigue or nausea.
At Crossroads Urology, our skilled team carefully monitors patients throughout the treatment to ensure safety and optimal outcomes.
Recovery and Post-Treatment Care
- Recovery time: Most patients resume normal activities immediately after each instillation.
- Post-procedure instructions: Maintain nephrostomy tube care and follow hydration recommendations.
- Follow-up: Regular imaging and urine cytology to assess treatment response.
Our team provides personalized aftercare instructions and ongoing support throughout the treatment course.
Benefits and Outcomes
Jelmyto therapy offers:
- Effective management of low-grade UTUC with minimal invasiveness.
- Kidney preservation by avoiding the need for surgical nephroureterectomy.
- High success rates in achieving complete response in treated areas.
Patients treated at Crossroads Urology experience excellent outcomes with this cutting-edge therapy.
Conclusion
Jelmyto instillation through a nephrostomy tube is a game-changing treatment for low-grade UTUC, offering effective, kidney-sparing therapy in a convenient outpatient setting. At Crossroads Urology, our expert team provides compassionate and advanced care to ensure the best outcomes for our patients. Contact us today to learn more about Jelmyto therapy and schedule your consultation.
